As of Mar 27
| +0.14 / +0.80%|
The 2 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.50, with a high estimate of 22.00 and a low estimate of 19.00. The median estimate represents a +16.74% increase from the last price of 17.56.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.